Cardio Diagnostics Holdings, Inc. (CDIO)

NASDAQ: CDIO · USD

$1.74

+0.04 (+2.1%)· Recorded snapshot

Market cap	5.1M
Revenue (ttm)	14.5K
Net income (ttm)	-6.5M
EPS (ttm)	-$2.76
Shares out	3M
Volume	8,752
Beta	2.24

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 14.5K
Net income (ttm): -6.5M
EPS (ttm): -$2.76
Market cap: 5.1M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	ホールド

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 13.4P50 20.2P75 35.7

Trailing P/En/a

P25 15.4P50 25.8P75 43.5

ROE-75.4

P25 -113.8P50 -46.5P75 -0.9

ROIC-44.5

P25 -68.5P50 -27.1P75 1.8

Benchmarks · 1M

All CDIO indicators

Market & fundamental data

Available fields

194

Groups with data

Currency

USD

Showing 194 of 194 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001870144
Company name	Cardio Diagnostics Holdings, Inc.
Country	United States
Country code	US
CUSIP number	14159C202
Earnings date	2026-11-11
Earnings time	amc
Employees	17
Employees change	2
Employees growth	13.33%
Enterprise value	$-82,320
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2017
Industry	Biotechnology
Is primary listing	Yes
Is SPAC	No
ISIN number	US14159C2026
Last 10-K release date	2026-03-13
Last earnings date	2026-08-07
Last refreshed	2026-10-28
Last stock split date	2025-05-13
Last stock split type	Reverse
Market cap	$5.1M
Market cap category	Nano-Cap
Next earnings date	2026-11-11
Options	No
Price	$1.74
Price currency	USD
Sector	Healthcare
SIC code	2835
Stock price date	2026-10-28
Symbol	CDIO
U.S. state	Illinois
Website	https://cdio.ai

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-158.99%
FCF / EV yield	3,133.07%
FCF yield	-115.77%
P/B ratio	0.68x
P/S ratio	348.17x
Price / tangible book value	0.78x
Sector forward P/E	23.56x
Sector P/E	50.13x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	100%
Operating margin	-44,690.68%
Pretax margin	-44,771.83%
Profit per employee	$-380,561
Revenue per employee	$850
ROA	-44.06%
ROA (5Y)	-65.08%
ROCE	-85.34%
ROE	-75.44%
ROE (5Y)	-145.38%
ROIC	-44.49%
SBC / revenue	677.72%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth quarters	2
EPS growth years	3
Gross profit growth	-25.92%
Gross profit growth (Q)	-28.29%
Gross profit growth 3Y	75.46%
Net income growth quarters	1
Net income growth years	1
Revenue growth	-25.92%
Revenue growth (Q)	-28.29%
Revenue growth (QoQ)	100%
Revenue growth 3Y	75.46%
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-164,594
Depreciation and amortization	$373,758
EBIT	$-6.5M
EBITDA	$-6.1M
EPS	$-2.76
FCF per share	$-1.97
Financing cash flow	$3.7M
Free cash flow	$-5.8M
Free cash flow minus SBC	$-5.9M
Gross profit	$14,450
Investing cash flow	$-446,663
Net borrowing	$-346,481
Net cash flow	$-2.4M
Net income	$-6.5M
Operating cash flow minus SBC	$-5.8M
Operating income	$-6.5M
Revenue	$14,450
Stock-based compensation	$97,930

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	-0.24
Book value per share	$2.51
Debt / equity	0.05
Interest coverage	-525.07
Long-term assets	$1.8M
Long-term liabilities	$140,583
Net cash (debt)	$5.2M
Net cash / market cap	103.7%
Net cash growth	-28.96%
Net debt / equity	-0.7
Piotroski F-Score	1
Property, plant and equipment	$782,472
Shareholders' equity	$7.4M
Tangible book value	$6.5M
Tangible book value per share	$2.18
Total assets	$7.9M
Total cash	$5.6M
Total debt	$369,698
Total liabilities	$499,780
WACC	15.6%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0
Current assets	$6.2M
Current liabilities	$359,197
Current ratio	17.15
Net working capital	$443,180
Quick ratio	15.56
Working capital	$5.8M
Working capital turnover	0

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-68.88%
Dividend yield	0%
Shareholder yield	-68.88%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	$1.87
1D price change	2.06%
1M price change	-11.03%
1M total return	-11.03%
1W price change	-1.98%
1W total return	-1.98%
1Y price change	-55.63%
1Y return CAGR	-55.65%
1Y total return	-55.63%
20-day SMA	$1.80
200-day SMA	$2.07
3M price change	7.1%
3M total return	7.1%
3Y price change	-74.73%
3Y return CAGR	-36.77%
3Y total return	-74.73%
50-day SMA	$1.89
50-day SMA vs 200-day SMA	50under200
52-week high	$7.91
52-week high date	2026-02-27
52-week low	$0.97
52-week low date	2026-02-06
6M price change	-4.67%
6M total return	-4.67%
All-time high	$307.50
All-time high date	2022-10-17
All-time low	$0.97
All-time low date	2026-02-06
Average true range (ATR)	$0.12
Average volume	26.7K
Beta (1Y)	2.97
Beta (2Y)	2.69
Beta (5Y)	2.24
Change from 52-week high	-78.07%
Change from 52-week low	78.87%
Change from all-time high	-99.44%
Change from all-time low	78.87%
Change from open	2.66%
Day's gap	-0.59%
Dollar volume	$15,185
High price	$1.77
Low price	$1.69
Monthly RSI	33.87
Open price	$1.69
Position in 52-week range	60%
Premarket change	1.77%
Premarket close	$1.70
Premarket price	$1.73
Premarket volume	354
Previous close	$1.70
Price vs 150-day SMA	-6.97%
Price vs 20-day SMA	-3.5%
Price vs 200-day SMA	-16.14%
Price vs 50-day SMA	-8.06%
Relative volume	0.33
RSI	44.98
Sharpe ratio	0.07
Sharpe ratio (3Y)	0.48
Sortino ratio	0.18
Sortino ratio (3Y)	1.02
Volume	8.8K
Weekly RSI	43.64
YTD price change	-35.98%
YTD total return	-35.98%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	2.8M
Float percentage	95.85%
Shares change (QoQ)	4.18%
Shares change (YoY)	68.88%
Shares held by insiders	4.14%
Shares held by institutions	6.52%
Shares outstanding	3M
Short % of float	0.04%
Short % of shares	0.03%
Short ratio	0 days

Deeper analysis on CDIO

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this CDIO report

Is a complete CDIO research report available?

No complete published report is available for Cardio Diagnostics Holdings, Inc. (CDIO) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Cardio Diagnostics Holdings, Inc. (CDIO)

Price

Financial snapshot

Fair-value bridge

Latest news · CDIO

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All CDIO indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on CDIO

Frequently asked questions